Altamira Therapeutics Ltd. (CYTO)
Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China
Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 5, 2026 in Inspire Medical Systems, Inc. Lawsuit - INSP
Perrigo Company plc Class Action: Levi & Korsinsky Reminds Perrigo Company plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - PRGO
Investors who lost money on DexCom, Inc. (DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM
Shareholders of Integer Holdings Corporation Should Contact Levi & Korsinsky Before February 9, 2026 to Discuss Your Rights - ITGR
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
Mirum Pharma - Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX
Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX
Outlook Therapeutics Reports Financial Results for Fiscal Year 2025
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis